Living Donor Liver Transplant (LDLT) Living donor liver transplant (LDLT) is an advanced surgical procedure in which a healthy person donates a portion of their liver to a patient suffering from end-stage liver disease. The liver is unique because it has the ability to regenerate; both the donated portion in the donor and the remaining liver in the recipient grow back to near-normal size within a few months. LDLT has become a lifesaving option, especially in countries where deceased donor organs are limited. LDLT is commonly performed for patients with conditions such as liver cirrhosis, chronic hepatitis B or C, fatty liver–related cirrhosis, biliary atresia in children, acute liver failure, and selected cases of liver cancer. Donors are usually close family members or relatives, although unrelated donors may also be considered after strict legal and ethical evaluation. Donor safety is the highest priority, and only medically and psychologically fit individuals are allowed to donate. Before the transplant, both donor and recipient undergo detailed evaluations, including blood tests, imaging studies, liver function tests, and psychological assessments. In the surgery, a part of the donor’s liver (right or left lobe, depending on recipient size) is removed and transplanted into the recipient after removing the diseased liver. The procedure requires high surgical expertise due to complex blood vessels and bile ducts. After transplantation, recipients need lifelong immunosuppressive medicines to prevent organ rejection. Regular follow-up is essential to monitor liver function and detect complications early. Possible risks include infection, bile leakage, rejection, or vascular problems, but outcomes have improved significantly with modern techniques. In conclusion, living donor liver transplant is a highly effective and life-saving treatment for advanced liver disease. With careful donor selection and experienced transplant teams, LDLT offers excellent long-term survival and a renewed quality of life for patients.